Valproate MDS suitability — GPhC CRA MCQ
Instant feedback + full explanation. One question, done properly.
Educational content. Not a substitute for clinical judgement or local policy.
Reveal the answer and explanation
Correct answer: E — Assess stability and valproate safety issues before MDS supply
MDS supply requires consideration of medicine stability, packaging requirements and patient-specific safety information. Valproate also carries important reproductive safety warnings for women of childbearing potential. The pharmacist should ensure counselling, risk materials and appropriate packaging decisions are in place.
Reference: BNF; SmPC; MHRA Drug Safety Update